Ratings
0
Nobody has rated this yet. Be the first!
Works
12
Activated PD-1+ CD4+ T cells represent a short-lived part of the viral reservoir and predict poor immunologic recovery upon initiation of ART
Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study
Identification and visualization of multidimensional antigen-specific T-cell populations in polychromatic cytometry data.
Structural Characterization of Immune Responses to HPV Infection and HPV Vaccination
Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study
Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials
HIV-1 Gag co-opts a cellular complex containing DDX6, a helicase that facilitates capsid assembly
1272. Feasibility and Successful Enrollment in Proof-of-Concept Trials to Assess Safety and Efficacy of a Broadly Neutralizing Monoclonal Antibody, VRC01, to Prevent HIV-1 Acquisitionin in Uninfected Individuals
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial
